| N = 50 | N = 45 |
---|---|---|
All included patients | Patients included in the point accuracy analysis | |
Age in years, median (IQR) | 65 (56-72) | 65 (55-72) |
Male gender, number (%) | 25 (50%) | 24 (53%) |
Race, number (%) | Â | Â |
  Caucasian | 45 (90%) | 40 (89%) |
  Black | 4 (8%) | 4 (9%) |
  Asian | 1 (2%) | 1 (2%) |
BMI in kg/m2, median (IQR) | 24.7 (22.4-27.6) | 24.4 (22.2-27.3) |
Admission diagnosis, number (%) | Â | Â |
  Medical | 31 (62%) | 26 (58%) |
  Emergency surgery | 11 (22%) | 11 (24%) |
  Planned surgery | 8 (16%) | 8 (18%) |
Planned admission, number (%) | 10 (20%) | 9 (20%) |
History of diabetes, number (%) | Â | Â |
  No diabetes | 39 (78%) | 34 (76%) |
  Diabetes, unknown treatment | 2 (4%) | 2 (4%) |
  Diabetes treated with insulin | 4 (8%) | 4 (9%) |
  Diabetes treated with oral agents | 5 (10%) | 5 (12%) |
APACHE II score, median (IQR) | 23 (17-26) | 22 (17-25) |
SAPS II, median (IQR) | 46 (39-55) | 46 (40-55) |
ICU LOS in days, median (IQR) | 9 (4-16) | 11 (5-16) |
Hospital LOS in days, median (IQR) | 19 (10-35) | 19 (11-35) |
ICU mortality, number (%) | 11 (22%) | 10 (22%) |
Hospital mortality, number (%) | 15 (30%) | 14 (31%) |